Abbott Wins FDA Approval For Two Over-The-Counter Diabetes Trackers

Abbott Labs News

Abbott Wins FDA Approval For Two Over-The-Counter Diabetes Trackers
AbbottDiabetesOTC
  • 📰 ForbesTech
  • ⏱ Reading Time:
  • 62 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 59%

I've written about health care for three decades, starting from my native Iowa where I covered the presidential campaign bus rides of Bill and Hillary Clinton through the Hawkeye state talking health reform and the economy.

two new over-the-counter continuous glucose monitoring systems, devices that could bring more access to millions of people with diabetes. In this photo, Abbott CEO Robert Ford speaks at last year's HLTH conference about the devices which were in development at that time. Abbott has been investing in wearables in these devices known as “biowearables,” the company’s CEO said at HLTH 2023 in Las Vegas Tuesday, October 10, 2023. Abbott Laboratories Monday said the U.S.

"There is no one-size-fits all approach for glucose monitoring, which is why we’ve designed different products for different people – all based on the same world-leading biowearable technology," said Lisa Earnhardt, executive vice president and group president of Abbott’s medical devices business."People living with diabetes need certain features like tracking medications or sharing data with a healthcare provider.

This new category of consumer biowearables, which attach beneath the skin to give more precise and accurate data about what is going on in someone’s body, is the latest evolution in medical devices for Abbott. The healthcare company is already known for its nutritionals franchise led by Similac baby formula, established pharmaceuticals and diagnostic tests for everything from the HIV virus and cancer to its top-selling array of tests for Covid viruses and its latest variants.

Biden Vs Trump 2024 Election Polls Most Voters Say Trump s Conviction Isn t A Factor Latest Survey ShowsAbbott chief executive Robert Ford opened a window into the company’s push to bring biowearables to the market at last year’s HLTH conference in Las Vegas during a keynote address.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ForbesTech /  🏆 318. in US

Abbott Diabetes OTC

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA approves two new Abbott over-the-counter continuous glucose monitorsFDA approves two new Abbott over-the-counter continuous glucose monitorsAbbott has FDA clearance for two new over-the-counter continuous glucose monitoring systems
Read more »

FDA approves two new Abbott over-the-counter continuous glucose monitorsFDA approves two new Abbott over-the-counter continuous glucose monitorsAbbott has FDA clearance for two new over-the-counter continuous glucose monitoring systems
Read more »

Greg Abbott Mocks Joe Biden's Approval Rating: 'Ouch'Greg Abbott Mocks Joe Biden's Approval Rating: 'Ouch'The Republican governor of Texas suggested that Biden's approval rating had dropped after Donald Trump's conviction.
Read more »

FDA panel votes against MDMA for PTSD, setting up hurdle to approvalFDA panel votes against MDMA for PTSD, setting up hurdle to approvalFDA advisers cited a variety of concerns with the trials submitted by Lykos Therapeutics as part of the application.
Read more »

Psychedelic drug MDMA faces questions as FDA considers approval for PTSDPsychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the medical mainstream.
Read more »

Psychedelic drug MDMA faces questions as FDA considers approval for PTSDPsychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the medical mainstream.
Read more »



Render Time: 2025-02-19 18:39:41